ARMISTICE CAPITAL, LLC

Insider Reports History

Location
New York, NY
Signature
ARMISTICE CAPITAL, LLC, Name: /s/ Steven Boyd, Title: Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ARMISTICE CAPITAL, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
ReShape Lifesciences Inc. 10%+ Owner Common Stock 7,223,346 $39,583,936 $5.48 28 Jun 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Common Stock 7,223,346 $39,583,936 $5.48 28 Jun 2021 Indirect
AYTU BIOPHARMA, INC Director Common Stock 1,342,378 $2,508,904 $1.87 29 Mar 2021 Direct
AYTU BIOPHARMA, INC Director Common Stock 1,342,378 $2,508,904 $1.87 29 Mar 2021 Indirect
EYEGATE PHARMACEUTICALS INC 10%+ Owner Common Stock 785,000 $541,650 $0.6900 02 Aug 2021 Indirect
Avalo Therapeutics, Inc. 10%+ Owner Common Stock 731,458 $379,919 $0.5194 27 Jun 2023 Indirect
Avalo Therapeutics, Inc. 10%+ Owner Common Stock 34,370 $17,852 $0.5194 26 Jun 2023 Direct
TENAX THERAPEUTICS, INC. Director Pre-Funded Common Stock Purchase Warrants 10,596,027 18 May 2022 Indirect
TENAX THERAPEUTICS, INC. Director Series C Common Stock Purchase Warrants 10,596,027 18 May 2022 Indirect
TENAX THERAPEUTICS, INC. Director Warrant (right to buy) 4,773,269 18 May 2022 Indirect
TENAX THERAPEUTICS, INC. Director Series B Common Stock Purchase Warrants 3,175,924 18 May 2022 Indirect
ReShape Lifesciences Inc. 10%+ Owner Common Stock, $.001 par value per share 2,409,342 15 Jun 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Common Stock, $.001 par value per share 2,409,342 15 Jun 2021 Indirect
TENAX THERAPEUTICS, INC. Director Common Stock Purchase Warrants 2,072,538 18 May 2022 Indirect
Avalo Therapeutics, Inc. 10%+ Owner Warrant 450,000 07 Feb 2023 Indirect
EYEGATE PHARMACEUTICALS INC 10%+ Owner Series C Convertible Preferred Stock 0 27 Jul 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Series A Warrants 0 28 Jun 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Series A Warrants 0 28 Jun 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Series E Warrants 0 28 Jun 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Series E Warrants 0 28 Jun 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Series G Warrants 0 28 Jun 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Series G Warrants 0 28 Jun 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Warrant 0 28 Jun 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Warrant 0 28 Jun 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Common Stock 0 15 Jun 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Common Stock 0 15 Jun 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Series A Warrants 0 15 Jun 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Series A Warrants 0 15 Jun 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Series E Warrants 0 15 Jun 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Series E Warrants 0 15 Jun 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Series G Warrants 0 15 Jun 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Series G Warrants 0 15 Jun 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Warrant 0 15 Jun 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Warrant 0 15 Jun 2021 Indirect

Insider Reports Filed by ARMISTICE CAPITAL, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTX Avalo Therapeutics, Inc. 26 Jun 2023 2 -$2,168,897 4 10%+ Owner 28 Jun 2023, 18:12
AVTX Avalo Therapeutics, Inc. 03 Feb 2023 3 +$1,319 4 10%+ Owner 09 Feb 2023, 15:32
TENX TENAX THERAPEUTICS, INC. 18 May 2022 12 $0 4 Director 19 May 2022, 21:24
AVTX Avalo Therapeutics, Inc. 10 Mar 2022 3 +$151,946 4 Director, 10%+ Owner 14 Mar 2022, 17:38
AVTX Avalo Therapeutics, Inc. 03 Mar 2022 3 +$344,132 4 Director, 10%+ Owner 07 Mar 2022, 17:09
AVTX Avalo Therapeutics, Inc. 24 Feb 2022 2 +$111,806 4 Director, 10%+ Owner 28 Feb 2022, 16:53
AVTX Avalo Therapeutics, Inc. 17 Feb 2022 3 +$231,564 4 Director, 10%+ Owner 22 Feb 2022, 17:37
AVTX Avalo Therapeutics, Inc. 18 Jan 2022 3 +$274,486 4 Director, 10%+ Owner 20 Jan 2022, 17:14
AVTX Avalo Therapeutics, Inc. 12 Jan 2022 3 +$452,768 4 Director, 10%+ Owner 14 Jan 2022, 16:49
AVTX Avalo Therapeutics, Inc. 07 Jan 2022 3 +$642,931 4 Director, 10%+ Owner 11 Jan 2022, 17:18
AVTX Avalo Therapeutics, Inc. 15 Sep 2021 3 +$12,557,902 4 Director, 10%+ Owner 17 Sep 2021, 14:25
AVTX Cerecor Inc. 16 Aug 2021 2 +$138,188 4 Director, 10%+ Owner 18 Aug 2021, 17:54
AVTX Cerecor Inc. 04 Aug 2021 3 +$408,515 4 Director, 10%+ Owner 06 Aug 2021, 15:15
KPRX EYEGATE PHARMACEUTICALS INC 30 Jul 2021 2 -$646,608 4 10%+ Owner 03 Aug 2021, 17:09
KPRX EYEGATE PHARMACEUTICALS INC 27 Jul 2021 9 -$10,454,264 4 Director, 10%+ Owner 29 Jul 2021, 19:59
TENX TENAX THERAPEUTICS, INC. 08 Jul 2021 2 $0 4 Director 09 Jul 2021, 18:03
RSLS ReShape Lifesciences Inc. 28 Jun 2021 24 $0 4 10%+ Owner 29 Jun 2021, 21:44
RSLS ReShape Lifesciences Inc. 16 Jun 2021 12 -$14,230,402 4 10%+ Owner 22 Jun 2021, 08:58
RSLS ReShape Lifesciences Inc. 15 Jun 2021 0 $0 3 10%+ Owner 22 Jun 2021, 08:49
RSLS ReShape Weightloss Inc. 15 Jun 2021 14 $0 4 10%+ Owner 22 Jun 2021, 08:33
AVTX Cerecor Inc. 14 May 2021 6 +$392,460 4 Director, 10%+ Owner 18 May 2021, 18:15
AYTU AYTU BIOPHARMA, INC 20 Mar 2021 4 $0 4 Director 10 May 2021, 21:25